Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
Clinical trial NCT04082416 · COMPLETED
Trial details
- NCT number
- NCT04082416
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2022-04-24
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.